On the frontiers of cyborg science. Step 1 – connecting the brain and electronics
Taking the human-machine concept to an unprecedented level, pioneering scientists are working on the seamless marriage between electronics and brain signaling with the potential to transform our understanding of how the brain works — and how to treat its most devastating diseases. The research titled "Nanoelectronics meets biology: From new tools to electronic therapeutics" will be presented at the 248th National Meeting & Exposition of the American Chemical Society (ACS) in San Francisco, August 10 – 14, 2014.
Cyborg technology is already bringing us tangible progress toward real-life electronic skin, prosthetics and ultraflexible circuits. Its nanoscale materials enable unique opportunities at the interface between the physical and life sciences, and the interfaces between nanoelectronic devices and cells, cell networks, and tissue makes possible communication between these systems at the length scale relevant to biological function.
In this presentation, researchers will be discussing the development of nanowire nanoelectronic devices and their application as powerful tools for the recording and stimulation from the level of single cells to tissue. They will present a brief introduction to nanowire nanoelectronic devices as well as comparisons to other tools to illuminate the unique strengths and opportunities enabled by active electronic devices. They promise to take an 'out-of-the-box' look and consider merging nanoelectronics with cell networks in three-dimensions (3D).
"By focusing on the nanoelectronic connections between cells, we can do things no one has done before," says Charles M. Lieber, Ph.D. "We're really going into a new size regime for not only the device that records or stimulates cellular activity, but also for the whole circuit. We can make it really look and behave like smart, soft biological material, and integrate it with cells and cellular networks at the whole-tissue level. This could get around a lot of serious health problems in neurodegenerative diseases in the future."
These disorders, such as Parkinson's, that involve malfunctioning nerve cells can lead to difficulty with the most mundane and essential movements that most of us take for granted: walking, talking, eating and swallowing.
Scientists are working furiously to get to the bottom of neurological disorders. But they involve the body's most complex organ — the brain — which is largely inaccessible to detailed, real-time scrutiny. This inability to see what's happening in the body's command center hinders the development of effective treatments for diseases that stem from it.
By using nanoelectronics, it could become possible for scientists to peer for the first time inside cells, see what's going wrong in real time and ideally set them on a functional path again.
For the past several years, Lieber has been working to dramatically shrink cyborg science to a level that's thousands of times smaller and more flexible than other bioelectronic research efforts. His team has made ultrathin nanowires that can monitor and influence what goes on inside cells. Using these wires, they have built ultraflexible, 3-D mesh scaffolding with hundreds of addressable electronic units, and they have grown living tissue on it. They have also developed the tiniest electronic probe ever that can record even the fastest signaling between cells.
Rapid-fire cell signaling controls all of the body's movements, including breathing and swallowing, which are affected in some neurodegenerative diseases. And it's at this level where the promise of Lieber's most recent work enters the picture.
In one of the lab's latest directions, Lieber's team is figuring out how to inject their tiny, ultraflexible electronics into the brain and allow them to become fully integrated with the existing biological web of neurons. They're currently in the early stages of the project and are working with rat models.
"It's hard to say where this work will take us," he says. "But in the end, I believe our unique approach will take us on a path to do something really revolutionary."
Source: American Chemical Society
Featured image: "Cyborg" by Linus Bohman (CC – Flickr)
If you value what we do here, create your ad-free account and support our journalism.
Your support makes a difference
Dear valued reader,
We hope that our website has been a valuable resource for you.
The reality is that it takes a lot of time, effort, and resources to maintain and grow this website. We rely on the support of readers like you to keep providing high-quality content.
If you have found our website to be helpful, please consider making a contribution to help us continue to bring you the information you need. Your support means the world to us and helps us to keep doing what we love.
Support us by choosing your support level – Silver, Gold or Platinum. Other support options include Patreon pledges and sending us a one-off payment using PayPal.
Thank you for your consideration. Your support is greatly appreciated.
Commenting rules and guidelines
We value the thoughts and opinions of our readers and welcome healthy discussions on our website. In order to maintain a respectful and positive community, we ask that all commenters follow these rules:
We reserve the right to remove any comments that violate these rules. By commenting on our website, you agree to abide by these guidelines. Thank you for helping to create a positive and welcoming environment for all.
If I had a dollar for every time some new technical nonsense promises to treat the most devastating diseases, well, I'd have a ton of dollars. It is well understood by people in the know that Alzheimer is an iatrogenic disease – i.e. cause by doctors recommendations to avoid cholesterol. Truth is most disease, especially the so called degenerative ones are really nutritional deficiencies easily cured by appropriate diet and supplements.